
CAS Name: [[8-Chloro-3-[2-(diethylamino)ethyl]-4-methyl-2-oxo-2H-1-benzopyran-7-yl]oxy]acetic acid ethyl ester
Additional Names: ethyl [[8-chloro-3-[2-(diethylamino)ethyl]-4-methyl-2-oxo-2H-1-b...
Literature References: Derivative of coumarin, q.v. Prepn: F. della Valle, BE 871315; idem, US 4452811 (1979, 1984 both to Fidia). In vivo studies of activity as coronary vasodilator: F. Aporti et al., Pharmacol. Res. Commun. 10, 469 (1978); as inhibitor of platelet aggregation: M. Prosdocimi et al., Thromb. Res. 39, 399 (1985). Pharmacology in human platelets: R. A. Travagli et al., ibid. 54, 327 (1989). Mechanism of action: S. Porcellati et al., Agents Actions 29, 364 (1990).
CAS Name: (6a,11b,16a,17a)-6,9-Difluoro-11-hydroxy-16-methyl-3-oxo-17-(1-oxopropoxy)androsta-1,4-diene-17-carbothioic acid S-(fluoromethyl) ester
Additional Names: S-fluoromethyl 6a,9a-difluoro...
Literature References: Derivative of flumethasone, q.v. Prepn: NL 81 00707; G. H. Phillipps et al., US 4335121 (1981, 1982 both to Glaxo). Series of articles on structure-activity, pharmacology and clinical studies: Respir. Med. 84, Suppl. A, 19-35 (1990). Clinical trials in allergic rhinitis: E. O. Meltzer et al., J. Allergy Clin. Immunol. 86, 221 (1990). Evaluation in untreated celiac disease: H. C. Mitchison et al., Gut 32, 260 (1991). Clinical trials in COPD: P. L. Paggiaro et al., Lancet 351, 773 (1998); P. S. Burge et al., Br. Med. J. 320, 1297 (2000). Clinical comparison with zafirlukast, q.v., in persistant asthma: J. H. Brabson et al., Am. J. Med. 113, 15 (2002).
CAS Name: (4R)-1-Acetyl-4-hydroxy-L-proline
Additional Names: 4-hydroxy-N-acetylproline; 1-acetyl-4-hydroxy-2-pyrrolidinecarboxylic acidTrademarks: Jonctum (Hoechst)
Percent Composition: C 4...
Literature References: Derivative of hydroxyproline having anti-inflammatory activity. Prepn: R. L. M. Synge, Biochem. J. 33, 1924 (1939); J. J. Kolb, G. Toennies, J. Biol. Chem. 144, 193 (1942); O. Leonardo et al., DE 2301358 corresp to US 3860607 (1973, 1975 to Richardson-Merrell). Elucidation of cyclic conformation and cis/trans isomerism about the amide bond: T. Prange et al., Biochem. Biophys. Res. Commun. 61, 104 (1974). Crystal structure: M. Hospital et al., Biopolymers 18, 1141 (1979). In crystals, the acetyl group is in the trans conformation and the ring is puckered. The trans form is more stable than the cis form in solutions: W. A. Thomas, M. K. Williams, J. Chem. Soc. Chem. Commun. 1972, 994. Anti-inflammatory and wound-healing activity in animals: P. Coirre, B. Coirre, GB 1246141 (1971) related to P. Coirre et al., US 3891765 and US 3932638 (1975, 1976 both to Franco Chimie). Clinical studies of use in several rheumatic conditions: P. Grellat, Rhumatologie 27, 223 (1975); in degenerative joint disease, R. Schubotz, L. Hausmann, Therapiewoche 27, 4248 (1977); in treatment of burns, tumors and other wounds (applied locally): Y. Privat, Gaz. Med. Fr. 84, 618 (1977).
CAS Name: 3-Benzoyl-a-methyl-N-(4-methyl-2-pyridinyl)benzeneacetamide
Additional Names: m-benzoyl-N-(4-methyl-2-pyridyl)hydratropamide; 2-(3-benzoylphenyl)-N-(4-methyl-2-pyridyl)propionamide
CAS Name: Cellulose 2-hydroxypropyl methyl ether
Additional Names: hypromellose; HPMC
Trademarks: Artelac (Mann); Benecel MP (Hercules); GenTeal (Novartis); Gonak (Akorn); Goniosol (Novartis...
Literature References: Derivative of methylcellulose, q.v., that also contains 3-12% hydroxypropyl substitution. Prepn: A. B. Savage, US 2949452 (1960 to Dow). Review of chemistry, physical properties and use: idem, Encyclopedia of Polymer Science and Technology vol. 3 (Interscience, New York, 1965); pp 496-511; G. K. Greminger, A. B. Savage, Industrial Gums, R. L. Whistler, Ed. (Academic Press, New York, 1973) pp 619-647. Clinical efficacy as ocular lubricant in Sjogren's syndrome: I. Toda et al., Cornea 15, 120 (1996); in contact lens solutions: P. A. Simmons et al., CLAO J. 27, 192 (2001). Review of production and uses in foods: P. de Mariscal, D. A. Bell in Handbook of Fat Replacers, S. Roller, S. A. Jones, Eds. (CRC Press, Boca Raton FL, 1996) pp 145-159. Review of drug release from HPMC-based pharmaceutical systems: J. Siepmann, N. A. Peppas, Adv. Drug Delivery Rev. 48, 139-157 (2001).
CAS Name: (3aS,4R,5S,6S,8R,9R,9aR,10R)-[[2-(Diethylamino)ethyl]thio]acetic acid 6-ethenyldecahydro-5-hydroxy-4,6,9,10-tetramethyl-1-oxo-3a,9-propano-3aH-cyclopentacycloocten-8-yl ester
Addition...
Literature References: Derivative of pleuromutilin, q.v. Prepn: H. Egger, DE 2248237 corresp to US 3919290 (1973, 1975 both to Sandoz); H. Egger, H. Reinshagen, J. Antibiot. 29, 915 (1976). Biosynthesis: F. Knauseder, E. Brandl, ibid. 125. In vitro activity: H. Werner et al., ibid. 31, 756 (1978). Metabolism: J. Dreyfuss et al., ibid. 32, 496 (1979). Effect vs Mycoplasma: C. O. Baughn et al., Avian Dis. 22, 620 (1978); R. F. Goodwin, Vet. Rec. 104, 194 (1979). Mechanism of action: G. Högenauer in Antibiotics vol. 5(pt. 1), F. E. Hahn, Ed. (Springer-Verlag, New York, 1979) pp 344-360. Treatment of swine dysentery: M. D. Anderson, Vet. Med. Small Anim. Clin. 78, 98 (1983).
CAS Name: (2E,11a,13E,15S,17S)-11,15-Dihydroxy-17,20-dimethyl-9-oxoprosta-2,13-dien-1-oic acid
Additional Names: 17S,20-dimethyl-trans-2,3-didehydro-PGE1; 9-oxo-11a,15a-dihydroxy-17S,20-dimethy...
Literature References: Derivative of prostaglandin E1, q.v. Prepn: M. Hayashi et al., DE 3002677 (1980 to Ono); eidem, US 4294849 (1981 to Warner-Lambert). Cardiovascular pharmacology in animals: T. Tsuboi et al., Arch. Int. Pharmacodyn. 247, 89 (1980). Effect on smooth muscle in vitro: P. G. Adaikan, S. M. M. Karim, Prostaglandins Med. 6, 449 (1981). Coronary vasodilating effects in primates: S. R. Kottegoda et al., Prostaglandins Leukotrienes Med. 8, 343 (1982). Clinical hemodynamics in chronic lung disease: T. Ishizaki et al., Chest 85, 382 (1984).
CAS Name: N-2-Benzothiazolyl-N,N'-dimethylurea
Additional Names: 1-(2-benzothiazolyl)-1,3-dimethylurea; metabenzthiazuron; MBUTrademarks: Tribunil (Bayer)
Percent Composition: C 54.28%, H 5....
Literature References: Derivative of urea. Prepn and use as pre-emergence herbicide: N. E. Searle, US 2756135 (1956 to du Pont). Use as pre- and post-emergence herbicide in wheat and barley: H. Hack et al., GB 1085430 (1967 to Bayer). Herbicidal properties: H. Hack, Pflanzenschutz-Nachr. 22, 331 (1969). Toxicity studies: G. Kimmerle, E. Löser, ibid. 351. Use in winter cereals: D. C. Clark et al., Proc. 12th Brit. Weed Control Conf. 163 (1974). Mode of action: G. F. Collet, Weed Res. 9, 340 (1969). Long-term effect on soil: P. L. Huge, Pflanzenschutz-Nachr. 34, 97 (1981). Brief review: P. Lours, Def. Veg. 24, 91 (1970).
Additional Names: Sodium acid acetate
Trademarks: Dykon
Percent Composition: C 33.81%, H 4.97%, Na 16.18%, O 45.04%
Literature References: Described as a "bound" compd of sodium acetate and acetic acid.
Additional Names: Monoxychlorosene
Trademarks: Clorpactin (Guardian); Clorpactin XCB (Guardian)
Percent Composition: C 59.02%, H 8.67%, Cl 8.71%, O 15.72%, S 7.88%
Literature References: Described as a buffered organic hypochlorous acid derivative with slightly acid pH. Contains a long chain hydrocarbon (surface-active agent). The chain (14 carbons) may be branched or straight but actually consists of a constant mixture having predominantly the straight chain. The hydrocarbon chain also has a phenyl substituent which in turn holds a sulfonic acid group. The complex corresponds to a formula: HO3S-C6H4-(C14H29).HOCl.
即日起可免费注册成为会员, 建立企业产品库, 免费上传产品目录, 企业介绍等. 让你的产品直接呈现给客户.
试运营阶段,所有广告业务5折优惠
